A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
- Daphne N. Weemering
- , Mark Midei
- , Peter Milner
- , Vidhya Gopalakrishnan
- , Anil Kumar
- , Andrew J. Dannenberg
- , Tommy M. Bunte
- , Juliette Foucher
- , Caroline Ingre
- , Viktorija Ķēniņa
- , Karin Rallmann
- , Leonard H. van den Berg
- , Ruben P.A. van Eijk*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review